These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7959868)

  • 41. Maximum growth rate of Mycobacterium avium in continuous culture or chronically infected BALB/c mice.
    McCarthy CM; Taylor MA; Dennis MW
    Microbios; 1987; 52(211):97-103. PubMed ID: 3695991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant interleukin-2 limits the replication of Mycobacterium lepraemurium and Mycobacterium bovis BCG in mice.
    Jeevan A; Asherson GL
    Lymphokine Res; 1988; 7(2):129-40. PubMed ID: 3043114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. I. Suppression of delayed-type hypersensitivity].
    Nakamura RM; Goto Y; Kinomoto M
    Kekkaku; 1990 Sep; 65(9):581-4. PubMed ID: 2232436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections.
    Appelberg R
    Immunobiology; 1994 Oct; 191(4-5):520-5. PubMed ID: 7713566
    [TBL] [Abstract][Full Text] [Related]  

  • 45. T cell-dependent chronic neutrophilia during mycobacterial infections.
    Appelberg R; Silva MT
    Clin Exp Immunol; 1989 Dec; 78(3):478-83. PubMed ID: 2575473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interleukin-12 primes CD4+ T cells for interferon-gamma production and protective immunity during Mycobacterium avium infection.
    Silva RA; Flórido M; Appelberg R
    Immunology; 2001 Jul; 103(3):368-74. PubMed ID: 11454066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune responsiveness in Mycobacterium avium-infected mice: changes in the proportion of T cell subsets and antibody production during the course of infection.
    Xu DL; Goto Y; Amoako KK; Nagatomo T; Uchida K; Shinjo T
    Clin Exp Immunol; 1995 Dec; 102(3):523-8. PubMed ID: 8536367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [In vitro and in vivo activities of chemically synthesized lipid A-subunit analogue, JTP3309, against mycobacterial infections in mice and in mouse peritoneal macrophages].
    Suzuki H; Saito H; Sato K; Tomioka H
    Kekkaku; 1995 Apr; 70(4):285-92. PubMed ID: 7760537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice.
    Stokes RW; Collins FM
    Clin Exp Immunol; 1990 Jul; 81(1):109-15. PubMed ID: 2116245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ag85-focused T-cell immune response controls Mycobacterium avium chronic infection.
    Cerqueira-Rodrigues B; Mendes A; Correia-Neves M; Nobrega C
    PLoS One; 2018; 13(3):e0193596. PubMed ID: 29499041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth of Mycobacterium avium in activated macrophages harvested from inbred mice with differing innate susceptibilities to mycobacterial infection.
    Stokes RW; Collins FM
    Infect Immun; 1988 Sep; 56(9):2250-4. PubMed ID: 3137164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-1 is involved in mouse resistance to Mycobacterium avium.
    Denis M; Ghadirian E
    Infect Immun; 1994 Feb; 62(2):457-61. PubMed ID: 8300206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction and expression of protective T cells during Mycobacterium avium infections in mice.
    Appelberg R; Pedrosa J
    Clin Exp Immunol; 1992 Mar; 87(3):379-85. PubMed ID: 1544223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protection of mice from Mycobacterium avium infection by recombinant interleukin-12.
    Kobayashi K; Kasama T; Yamazaki J; Hosaka M; Katsura T; Mochizuki T; Soejima K; Nakamura RM
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1369-71. PubMed ID: 7574533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of interleukin-12 in the long-term protection conferred by a Mycobacterium avium subunit vaccine.
    Silva RA; Pais TF; Appelberg R
    Scand J Immunol; 2000 Dec; 52(6):531-3. PubMed ID: 11119256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The thymus as a target for mycobacterial infections.
    Nobrega C; Cardona PJ; Roque S; Pinto do O P; Appelberg R; Correia-Neves M
    Microbes Infect; 2007; 9(14-15):1521-9. PubMed ID: 18062904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interleukin (IL)-12 deficiency in susceptible mice infected with Mycobacterium avium and amelioration of established infection by IL-12 replacement therapy.
    Kobayashi K; Yamazaki J; Kasama T; Katsura T; Kasahara K; Wolf SF; Shimamura T
    J Infect Dis; 1996 Sep; 174(3):564-73. PubMed ID: 8769615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T-cell immune responses in Mycobacterium avium-infected mice.
    Hubbard RD; Flory CM; Collins FM
    Infect Immun; 1992 Jan; 60(1):150-3. PubMed ID: 1729179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CD38 plays a role in effective containment of mycobacteria within granulomata and polarization of Th1 immune responses against Mycobacterium avium.
    Viegas MS; do Carmo A; Silva T; Seco F; Serra V; Lacerda M; Martins TC
    Microbes Infect; 2007 Jun; 9(7):847-54. PubMed ID: 17533152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minor role played by type I tumour necrosis factor receptor in the control of Mycobacterium avium proliferation in infected mice.
    Silva RA; Gomes MS; Appelberg R
    Immunology; 2000 Feb; 99(2):203-7. PubMed ID: 10692037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.